Harnessing the Power of Genomics and Proteomics - Part 2: Profiling Proteomics

Author：

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.1, Iss.1, 2003-01, pp. : 3-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Technology: methodologies in genomics and proteomics

By Jon T. John M. Chris M.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Genomics and Proteomics of Nucleoside Transporters

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-01 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

Companies Applying Genomics and Proteomics to Cancer

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 1, 2003-01 ,pp. : 60-63

Adis International

Access to resources Recommend Favorite

Genomics, proteomics: what’s next?

By Willett James D

Pharmacogenomics, Vol. 3, Iss. 6, 2002-11 ,pp. : 727-728

Future Medicine

Access to resources Recommend Favorite

Managing core resources for genomics and proteomics

By Apweiler Rolf Martin Maria Jesus O’Donovan Claire Pruess Manuela

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 343-350

Future Medicine

Access to resources Recommend Favorite